Emergence of TP53 mutation during lenalidomide therapy of myelodysplastic syndrome with del(5q) and its subsequent disappearance following salvage therapy with decitabine

在接受来那度胺治疗伴有del(5q)的骨髓增生异常综合征期间出现TP53突变，并在接受地西他滨挽救治疗后该突变消失。